Diana Langworthy, PharmD, BCPS
Associate Professor, Department of Pharmaceutical Care & Health Systems
.jpg)
Contact Info
Associate Professor, Department of Pharmaceutical Care & Health Systems
Clinical Pharmacist - Adult Internal Medicine, University of Minnesota Medical Center
Pharmacy Practice Residency (PGY-1), Virginia Commonwealth University Health System, Richmond, VA
Internal Medicine Pharmacy Residency (PGY-2), Virginia Commonwealth University Health System, Richmond, VA
PharmD, Ernest Mario School of Pharmacy, Rutgers University
Summary
Dr. Langworthy joined the University of Minnesota College of Pharmacy in 2016 in a joint position with the University of Minnesota Medical Center/Fairview. Her primary practice site is in Acute Care - Internal Medicine at the East Bank UMMC location. In this clinical role, she provides inpatient clinical pharmacy services to a diverse population of medically ill patients and serves as a preceptor to pharmacy students and residents. In addition, she serves as the coordinator for the Teaching Certificate Program for the UMMC Pharmacy Residents. Her past experiences include an Assistant Professor position at the Virginia Commonwealth University School of Pharmacy in Richmond, VA and an Internal Medicine clinical pharmacist position at the Mayo Clinic in Rochester, MN. Her clinical interests include gastroenterology, infectious diseases, and the effects of bariatric surgery on medication absorption.
Expertise
Adult Internal Medicine
Bariatric surgery and medication absorption
Awards & Recognition
Annual Teaching Excellence Award 2013 - Virginia Commonwealth University School of Pharmacy
Professional Associations
AACP
ACCP
Research
Research Summary/Interests
My primary research interest includes the effects of bariatric surgery on medication absorption. I am also interested in anticoagulation in special populations (i.e. obesity, renal impairment).
Publications
Mack DR, Cahoon WD, Lowe DK. Colchicine for the primary prevention of the postpericardiotomy syndrome. Ann Pharmacother 2011;45:803-6.
Mack DR, Gravatt LH, Harpe SE. Evaluation of infusion-related reactions with iron sucrose at a large tertiary medical center. Pharmacotherapy 2011;31(10):311e-453e.
Mack DR, Kim JJ. Pharmacokinetic and clinical implications of dabigatran use in severe renal impairment for stroke prevention in nonvalvular atrial fibrillation. Ann Pharmacother 2012;46(7-8):1105-10.
Kim JJ, Langworthy DR, Hennessey E. Clinical implications of statin therapy in patients undergoing hemodialysis. Am J Health-Syst Pharm 2014:71(9);703-10.
Kaufman KR, Thurber KM, O'Meara JG, Langworthy DR, Kashiwagi DT. Evaluation of cephalexin failure rates in morbidly obese patients with cellulitis. Journal of Clinical Pharmacy and Therapeutics 2016:41:409-13.
Roy D, Langworthy DR, Thurber KM, Lorentz P, Mundi M. Comparison of oral antibiotic failure rates in post Roux-en-Y gastric bypass patients versus controls. Poster Presentation. MSHP Annual Meeting 2016, St. Cloud, MN.
Clinical
Clinics
University of Minnesota Medical Center
Board Certifications
Board Certified Pharmacotherapy Specialist (BSPS)
Clinical Interests
Use of medications in special populations (i.e. obesity, renal & hepatic disease, elderly), oral drug absorption after bariatric surgery, anticoagulation, gastroenterology Care Philosophy: Every patient deserves the highest level of interprofessional care when they are requiring medical attention. My priority when caring for a patient is to create an individualized pharmacotherapy plan to ensure that the patient receives the safest and most effective medication regimen.